Astec Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar' 24	Dec' 23	Sep' 23	Jun' 23	Mar' 23

Sales

153.75

50.79

110.79

142.85

126.97

Operating profit

12.71

-18.33

-3.42

3.14

5.40

Interest

6.68

6.10

6.00

6.47

6.41

Gross profit

8.06

-23.53

-8.46

-1.63

1.56

EPS (Rs)

-0.50

-12.42

-6.86

-4.19

-2.55

Other income

2.03

0.90

0.96

1.70

2.57

Stock adjustment

22.82

-7.85

3.64

-18.16

9.76

Raw material

82.50

43.17

72.38

120.77

76.49

Power and fuel

-

-

-

-

-

Employee expenses

14.69

14.43

17.25

15.38

12.86

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

21.03

19.37

20.94

21.72

22.47

Provisions made

-

-

-

-

-

Depreciation

9.02

8.72

9.17

9.40

7.77

Taxation

0.03

-7.90

-4.19

-2.83

-1.22

Net profit / loss

-0.99

-24.35

-13.45

-8.21

-5.00

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

19.61

19.61

19.61

19.61

19.61

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

8.27

-36.08

-3.09

2.19

4.26

GPM (%)

5.18

-45.51

-7.57

-1.13

1.21

NPM (%)

-0.63

-47.10

-12.03

-5.68

-3.86